Novozymes is the world leader in bioinnovation, producing a wide range of industrial enzymes, microorganisms, and biopharmaceutical ingredients.
January 29 2015
On February 2, 2015, Novozymes will initiate a stock buyback program as announced in Company announcement No. 1 of January 20, 2015.
January 20 2015
Positive outlook for 2015. Long-term targets updated
October 23 2014
Increased expectations for full-year profit. 2014 sales growth on track
Den 2. februar 2015 vil Novozymes påbegynde et aktietilbagekøbsprogram, således som offentliggjort i selskabsmeddelelse nr. 1 af 20. januar 2015.
Positive forventninger til 2015. Langsigtede mål opdateret
Øgede forventninger til årets resultat. 2014-salgsvækst som forventet
Novozymes and Cargill remain committed to bringing technology to market
January 27 2015
Novozymes launches new purpose statement, strategy, and long-term targets.
The first full year trials show yield increases in corn and soy. Novozymes and Monsanto plan for expanded trials in 2015.
January 7 2015
| Copyright © 2015 Novozymes. All Rights Reserved.